Honeywell International Inc.

Industry

  • Digital Health
    • Disease Management
  • Diversified
See more in Biomedtracker

Latest on Honeywell International Inc.

Scrip

Asia Deal Watch: Otsuka’s Taiho Licenses LSD1 Inhibitor Rights To Benz

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, Vibha Ravi, and Sushmita Panda

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo

Generics Bulletin

Inhaler Changes For Environmental Reasons Worry Generic Sponsors, Prompt Call For FDA Research

 
• By Derrick Gingery

Sponsors of brand respiratory drugs are expected to remove hydrofluorocarbons as the device propellant, which could leave generic companies scrambling absent help from the US Food and Drug Administrat

Pink Sheet

Inhaler Changes For Environmental Reasons Worry Generic Sponsors, Prompt Call For FDA Research

 
• By Derrick Gingery

Sponsors of brand respiratory drugs are expected to remove hydrofluorocarbons as the device propellant, which could leave generic companies scrambling absent help from the US Food and Drug Administrat

Pink Sheet

Commissioner Nominee's Required Divestitures Illustrate US FDA's Broader Recruitment Challenge

 
• By Derrick Gingery

Stephen Hahn's financial disclosure and ethics agreements provide another example of the US Food and Drug Administration's difficulties recruiting external candidates for senior leadership positions.